Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells

被引：0
|
作者：
Xiaomin Feng
Hao Liu
Zhijie Zhang
Yixue Gu
Huisi Qiu
Zhimin He
机构：
[1] Cancer Hospital and Cancer Research Institute,
[2] Guangzhou Medical University,undefined
[3] Guangzhou,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 36卷
关键词：
Annexin A2; Cisplatin resistance; Apoptosis; p53; JNK; C-Jun; Non-small cell lung cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells
    Feng, Xiaomin
    Liu, Hao
    Zhang, Zhijie
    Gu, Yixue
    Qiu, Huisi
    He, Zhimin
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2017, 36
  • [2] ATF2 contributes to cisplatin resistance in non-small cell lung cancer and celastrol induces cisplatin resensitization through inhibition of JNK/ATF2 pathway
    Lo Iacono, Marco
    Monica, Valentina
    Vavala, Tiziana
    Gisabella, Mara
    Saviozzi, Silvia
    Bracco, Enrico
    Novello, Silvia
    Papotti, Mauro
    Scagliotti, Giorgio Vittorio
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (11) : 2598 - 2609
  • [3] Downregulated long non-coding RNA TRPM2-AS inhibits cisplatin resistance of non-small cell lung cancer cells via activation of p53-p66shc pathway
    Ma, L. -Y.
    Xie, X. -W.
    Ma, L.
    Pang, J. -L.
    Xiong, X. -M.
    Zheng, H. -D.
    Shen, X. -L.
    Wen, Z. -G.
    Wang, H. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (11) : 2626 - 2634
  • [4] Role of MetallothioneinlH in Cisplatin Resistance of Non-Small Cell Lung Cancer Cells
    Xin-fang Hou~(1*)
    2 Cancer Center of Zhengzhou University
    Department of Oncology
    3 Department of Etiology and Carcinogenesis
    ChineseJournalofCancerResearch, 2009, 21 (04) : 247 - 254
  • [5] CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway
    Wang, Li-Le
    Hu, Rui-Cheng
    Dai, Ai-Guo
    Tan, Shuang-Xiang
    Xu, Ming
    Kong, Chun-Chu
    Chen, Yun-Rong
    Fu, Dai-Yan
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (06): : 6279 - 6287
  • [6] Annexin A2 Silencing Induces G2 Arrest of Non-small Cell Lung Cancer Cells through p53-dependent and -independent Mechanisms
    Wang, Chi-Yun
    Chen, Chia-Ling
    Tseng, Yau-Lin
    Fang, Yi-Ting
    Lin, Yee-Shin
    Su, Wu-Chou
    Chen, Chien-Chin
    Chang, Kung-Chao
    Wang, Yi-Ching
    Lin, Chiou-Feng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (39) : 32512 - 32524
  • [7] Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
    Kang-Seo Park
    Hyun-Kyoung Kim
    Jung-Hwa Lee
    Yong-Bock Choi
    Seong-Yeol Park
    Sei-Hoon Yang
    Soo-Youl Kim
    Kyeong-Man Hong
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 493 - 502
  • [8] Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
    Park, Kang-Seo
    Kim, Hyun-Kyoung
    Lee, Jung-Hwa
    Choi, Yong-Bock
    Park, Seong-Yeol
    Yang, Sei-Hoon
    Kim, Soo-Youl
    Hong, Kyeong-Man
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (04) : 493 - 502
  • [9] Apoptosome pathway activation in non-small cell lung cancer cells and tissues
    Moravcikova, E.
    Krepela, E.
    Cermak, J.
    Benkova, K.
    FEBS JOURNAL, 2009, 276 : 265 - 265
  • [10] Huaier suppresses cisplatin resistance in non-small cell lung cancer by inhibiting the JNK/JUN/IL-8 signaling pathway
    Jin, Haoyi
    Liu, Changhao
    Liu, Xi
    Wang, Huan
    Zhang, Yi
    Liu, Yu
    Li, Jijia
    Yu, Zhanwu
    Liu, Hong-xu
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
12345